Predictive Financial Intelligence for Healthcare

See the financial outcome before you commit the spend.

Alpha VZN turns claims, reimbursement, price-transparency, and utilization data into a single decision-ready financial model — so MedTech teams, hospital finance leaders, and contracting teams can price, pitch, and approve with confidence instead of guesswork.

  • 190M+Negotiated rates ingested
  • 3,000+Hospitals modeled
  • 15,000+Procedures & codes mapped
Procedure Detail
CPT 33361 TAVR Financial Model MS-DRG 266 · inpatient-only
Revenue / case $62.4K
Contribution $17.9K$15.8K
Aetna DRG median $91,148
UHC DRG median $85,552
Labor cost$4.8K$6.1K
Disposable cost$32.5K$35.2K
GTM INTELLIGENCE Launch Economics
Annual TAVR cases116 Device cost / case$32.5K Revenue / case$62.4K Story statusCFO-ready
Build the buyer-ready financial case before the first pitch. Volume, reimbursement, device cost, and contribution become one account story.
VALUE ANALYSIS Product Economics
Revenue / case $62.4K
Variable cost $44.5K
Contribution $17.9K
Commercial mix Medicare mix 116 cases
Pressure-test adoption before spend is approved. Model margin, payer mix, labor, utilization, and cost with finance-ready assumptions.
CONTRACT NEGOTIATION Payer Rate Intelligence
Aetna comparable$91,148 UHC comparable$85,552
Negotiate from evidence, not anecdotes. Compare payer reimbursement against similar hospitals and markets before the table.
SERVICE LINE GROWTH Bronchoscopy with Biopsy
Monthly volume 80
Robot capital $650K
Disposable / case $1,850
Labor / case$1,200 Annual cases960
3-year net return$8.9M
Model return before capital is committed. At 80 cases per month, Alpha VZN can test robot cost, disposables, labor, and payer mix against a multi-year return.
Scroll
One engine over every U.S. reimbursement system
Medicare PFS OPPS / ASC MS-DRG (IPPS) Hospital price-transparency files Payer TiC

The problem

Great products die in the financial conversation, not the clinical one.

High-stakes healthcare decisions rarely fail for lack of effort. They fail because market, clinical, contracting, and finance assumptions live in separate rooms — so no one can see the full economic picture clearly enough to say yes in time.

Delayed

Decisions that stall

Value analysis committees wait on vendor-supplied projections that can't survive a rigorous financial review.

Missed

Adoption windows

MedTech teams pitch clinical value without knowing where a product fits a facility's DRG economics.

$B+

Left on the table

Contracting teams negotiate from anecdotes instead of benchmarked, facility-level reimbursement data.

Secure local modeling

Not another spreadsheet. A sharper way to see the decision.

Upload your hospital system rates locally and model against the contracts you actually live with. The data stays on your device, which means the financial scenario can become exact down to the dollar without sending your rates anywhere.

Hospital Workbench My Rates
Your data never leaves this browser

Rates are stored locally in this browser's database. They are never sent to Alpha VZN servers, never synced across devices, and never visible to anyone else.

Browser-local
CPT Procedure Payer Rate
33361 TAVR, femoral approach Aetna $91,148
33361 TAVR, femoral approach UnitedHealthcare $85,552
27447 Total knee arthroplasty Anthem BCBS $29,646
Commercial basis My uploaded rates

The product · Value-analysis modeler

Financial modeling grounded in the drivers that change the case.

TAVR example

See the margin story before adoption becomes spend.

Alpha VZN brings reimbursement basis, annual cases, payer mix, implant and disposable cost, labor expense, and contribution impact into one finance-ready view. Leaders can test whether a program or product strengthens the service line before the decision is committed.

Procedure scenario CPT 33361 | MS-DRG 266
Weighted revenue / case $62,400
Variable cost / case $44,500
Contribution / case $17,900
Volume 116 cases

Animated sensitivity range: 84 to 136 annual cases.

Labor expense $4,800

Clinical labor, room time, cath lab support, and staffing intensity.

Commercial
45% to 52%
Medicare
45% to 38%
Medicaid / self-pay
10%
Valve + disposables $32.5K
Labor $4.8K
Other variable $7.2K
Medicare margin $15.7K
Modeled 3-year contribution range $4.5M to $8.4M

Signature capabilities

Where the data becomes a decision.

An AI layer on top, two workhorse features underneath — all running on the same validated dataset.

Ask Alpha · AI

Ask anything. Get the number.

Ask Alpha turns the entire dataset into a conversation — instant contract comparisons, device integration planning, payer benchmarks, and margin questions answered in plain language, grounded in verified rates instead of a model's guess.

Contract Opportunity Finder

Find the money left on the table.

For any hospital, Alpha VZN surfaces every code × payer line where same-state peers are paid more — ranked by dollar gap, volume-weighted where Medicare data exists, and exportable as a branded negotiation packet.

Ranked byDollar gap
OutputNegotiation packet
Compliance & CMP exposure

Grade a hospital — or a whole system.

Score any facility A–F against federal price-transparency rules (45 CFR 180.50), with data-integrity checks that catch impossible rates and duplicates, then roll penalty exposure up across an entire multi-hospital system.

GradingA–F scorecard
RollupFleet-wide CMP

One dataset · Both sides of the table

Two products. One financial truth.

The same reimbursement engine is sold into the seller and the buyer — and each side pulls the other in. Reps demoing in the field create inbound from the CFOs and contracting teams they sell to.

Sell side

MedTech & device teams

Turn a clinical pitch into a CFO-ready financial case — from a single field rep up to an entire sales organization.

  • GTM intelligence Show value analysis exactly how your product moves the hospital P&L — per case, per site of service.
  • Account & territory intel Per-account reimbursement math and buyer-ready packets that create inbound from CFOs.
Buy side

Hospitals & health systems

Model adoption, benchmark contracts, and audit compliance — for one service line or an entire multi-hospital system.

  • Value analysis Drop in your own negotiated rates — browser-local — and run adoption scenarios against real contracts.
  • Price transparency Benchmark who pays what across hospitals by payer, with a compliance scorecard for posture.
  • Service line growth Roll up volume, cost, and contribution across every procedure in a program.

Shipping fast · Inside the platform today

Why it's defensible

The hard part isn't the data. It's making it trustworthy.

Signal from the noise

Public hospital price files are mostly noise. A multi-layer quality pipeline scans hundreds of millions of raw records and keeps only the rates that survive rigorous validation. The filtering is the moat.

Checked from both directions

Hospital-published rates are cross-referenced against payer Transparency-in-Coverage filings — the same negotiated rate seen from both sides of the contract. Nobody gets that confidence from one source alone.

Built to run lean

A fully client-side architecture with no customer data to secure means near-zero marginal cost — margins that scale with the dataset, not with headcount.

Alpha VZN regional pricing map with selected states highlighted for analysis

The opportunity

A market being forced into the open.

Federal price-transparency mandates are making this data exist for the first time — across 100K+ U.S. medical-device reps and every hospital and health system in the country. Legacy transparency platforms and sales-intelligence tools are desktop dashboards that require you to hand over your data. Alpha VZN is mobile-first, needs no data ingestion, and speaks to both the buyer and the seller.

100K+ U.S. medical-device reps on the sell side
Every U.S. hospital, now federally mandated to publish rates
  • Mobile-first
  • No data ingestion
  • Both sides of the table
  • Regional + payer context

“When both sides of the table can see the same number, the decision gets made.”

Read the full thesis →
Ryan Bell, Founder and CEO of Alpha VZN

Built by someone who lived the problem

Two decades in healthcare. One clear conviction.

Ryan Bell has spent more than two decades across hospital systems, medical-device commercialization, and health-system financial strategy — holding P&L responsibility for portfolios representing hundreds of millions in revenue, and sitting on both sides of the table when capital decisions are made. He built Alpha VZN to close the gap he watched sink great products: the absence of a shared financial lens.

Alpha VZN logo

Coming soon

Predictive clarity is becoming the new advantage.

Alpha VZN is being built for healthcare teams that need to understand the financial consequence of the next move before capital, contracting, or clinical adoption decisions are locked in.

Waitlist Enroll for early access

Prefer direct contact? Connect on LinkedIn